NCX Corporation
Raleigh, NC
- UEI
- E264TPYMXU97
- CAGE
- 9TJP8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 9310 Focal Pt, Raleigh, NC 27617, USA
- Website
- ncxtec.com
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $249,986 |
| FY2025 | $2,574,793 |
| FY2024 | $74,950 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of the Army | $249,986 |
Contract awards
Similar vendors
About the company
NCX Corporation, doing business as NCX Corp, is a minority-owned small disadvantaged business based in Raleigh, North Carolina, that develops advanced imaging and inspection technologies for defense applications, operating exclusively as a prime contractor on Small Business Innovation Research (SBIR) Phase I and Phase II awards from the Department of the Air Force and the Department of the Army. The company competes under total small business set-asides across its entire federal footprint.
NCX Corp's capability portfolio centers on nanotube-based imaging systems, 3D X-ray and tomography technologies, and non-destructive inspection systems for aircraft evaluation and explosive ordnance disposal applications. Representative work includes a $1.25 million Phase II SBIR award from the Air Force Research Laboratory for the VANTAGE (Versatile Array Nanotube Tomography for Advanced Ground Exploitation) project, extending through March 2027; a $1.25 million Phase II SBIR contract from AFRL for a multibeam 3D non-destructive inspection system for aircraft evaluation, completing July 2026; a $249,986 Phase I SBIR definitive contract from the Department of the Army under Topic A254-P039, completing October 2026; and a $74,886 Phase I SBIR purchase order from AFRL for a portable 3D X-ray system for explosive ordnance disposal and improvised explosive device scanning, completed in April 2025.
Customer concentration is narrow and research-focused. The Air Force Research Laboratory dominates the footprint with four awards worth $2.6 million combined potential value; the Department of the Army accounts for one award worth $250 thousand. All five awards are SBIR-designated (four Air Force, one Army), and all carry total small business set-aside designations. Combined potential value across the portfolio is $2.9 million, fully obligated. Activity shows three awards placed in 2025 and one in 2026 against one in 2024. Three awards (combined potential value $2.7 million) reach ultimate completion within the next twenty-four months, creating recompete exposure in the near term. NCX Corp operates with no subcontractors in its recent award footprint; all work is performed at the company's Raleigh facility under direct prime performance on federally funded research.
Quick answers
Is NCX Corporation registered in SAM.gov?
Yes. NCX Corporation's SAM.gov registration is active through August 25, 2027.
How much has NCX Corporation received in federal contracts?
Federal contracts obligated $2,574,793 to NCX Corporation in fiscal year 2025 and $2,899,729 in fiscal years 2023 through 2027.
What is NCX Corporation's most recent federal award?
NCX Corporation's most recent federal contract award is Sbir phase i, topic A254-P039 (W5170126CA150), from Department of the Army, on April 13, 2026.
On GovTribe
See NCX Corporation's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors